| Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo … D Michalickova, R Minic, N Dikic, M Andjelkovic, M Kostic-Vucicevic, ... Applied physiology, nutrition, and metabolism 41 (7), 782-789, 2016 | 90 | 2016 |
| Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis D Michaličková, T Hrnčíř, NK Canová, O Slanař European journal of pharmacology 873, 172973, 2020 | 86 | 2020 |
| Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets M Ľupták, D Michaličková, Z Fišar, E Kitzlerová, J Hroudová World Journal of Psychiatry 11 (7), 277, 2021 | 37 | 2021 |
| Comparison of polyphenol-enriched tomato juice and standard tomato juice for cardiovascular benefits in subjects with stage 1 hypertension: A randomized controlled study D Michaličková, M Belović, N Ilić, J Kotur-Stevuljević, O Slanař, S Šobajić Plant Foods for Human Nutrition 74, 122-127, 2019 | 36 | 2019 |
| Lactobacillus helveticus Lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial DM Michalickova, MM Kostic-Vucicevic, MD Vukasinovic-Vesic, ... The Journal of Strength & Conditioning Research 31 (1), 62-70, 2017 | 27 | 2017 |
| New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis D Michaličková, Š Martin, O Slanař Physiological Research 69 (1), 1, 2020 | 26 | 2020 |
| Effects of probiotic supplementation on selected parameters of blood prooxidant‐antioxidant balance in elite athletes: a double‐blind randomized placebo‐controlled study D Michalickova, J Kotur-Stevuljevic, M Miljkovic, N Dikic, ... Journal of human kinetics 64 (1), 111-122, 2018 | 26 | 2018 |
| No time dependence of ciprofloxacin pharmacokinetics in critically ill adults: comparison of individual and population analyses M Šíma, D Michaličková, P Ryšánek, P Cihlářová, M Kuchař, D Lžičařová, ... Pharmaceutics 13 (8), 1156, 2021 | 11 | 2021 |
| Edaravone attenuates disease severity of experimental auto-immune encephalomyelitis and increases gene expression of Nrf2 and HO-1 D Michaličková, HK Öztürk, J Hroudova, M L’UPTÁK, T KUČERA, ... Physiological Research 71 (1), 147, 2022 | 8 | 2022 |
| Changes in parameters of oxidative stress, immunity, and behavior in endurance athletes during a preparation period in winter D Michalickova, R Minic, J Kotur-Stevuljevic, M Andjelkovic, N Dikic, ... The Journal of Strength & Conditioning Research 34 (10), 2965-2973, 2020 | 8 | 2020 |
| Rapid increase in clearance of phenobarbital in neonates on extracorporeal membrane oxygenation: a pilot retrospective population pharmacokinetic analysis D Michalicková, P Pokorná, D Tibboel, O Slanar, CAJ Knibbe, ... Pediatric Critical Care Medicine 21 (9), e707-e715, 2020 | 7 | 2020 |
| Profiling of microorganism-binding serum antibody specificities in professional athletes R Minić, Z Papić, B Đorđević, D Michaličkova, V Ilić, G Mathiesen, ... Plos one 13 (9), e0203665, 2018 | 7 | 2018 |
| What is the best predictor of phenobarbital pharmacokinetics to use for initial dosing in neonates? M Šíma, D Michaličková, O Slanař Pharmaceutics 13 (3), 301, 2021 | 4 | 2021 |
| Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications JM Hartinger, D Michaličková, E Dvořáčková, K Hronová, EHJ Krekels, ... Pharmaceutics 15 (5), 1394, 2023 | 3 | 2023 |
| Superiority of ceftazidime off‐label high‐dose regimen in PK/PD target attainment during treatment of extensively drug‐resistant Pseudomonas aeruginosa infections in cancer … A Zavrelova, M Sima, J Malakova, P Rozsivalova, P Paterova, P Zak, ... British Journal of Clinical Pharmacology 89 (4), 1452-1461, 2023 | 3 | 2023 |
| Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation P Šantavý, M Šíma, O Zuščich, V Kubíčková, D Michaličková, O Slanař, ... Antibiotics 11 (11), 1582, 2022 | 3 | 2022 |
| Post-mortem Redistribution of Alprazolam in Rats J Hořínková, P Kozlík, T Křížek, D Michaličková, M Šíma, O Slanař Prague Medical Report 121 (4), 244-253, 2020 | 2 | 2020 |
| Food elimination based on immunoglobulin G antibodies improves gastrointestinal discomfort symptoms and sport performance in professional athletes M Kostic-Vucicevic, D Michalickova, N Dikic, T Stojmenovic, ... Medicina dello Sport 70 (4), 480-94, 2017 | 2 | 2017 |
| Detection of galanin receptors in the spinal cord in experimental autoimmune encephalomyelitis. D Michalickova, I Kramarikova, HK Ozturk, T Kucera, T Vacik, T Hrncir, ... Biomedical Papers of the Medical Faculty of Palacky University in Olomouc …, 2023 | 1 | 2023 |
| Targeting leukocytes in multiple sclerosis: Therapeutic perspectives D Michaličková, HK Öztürk, O Slanař Translational Neuroimmunology, Volume 8, 129-143, 2023 | 1 | 2023 |
